4//SEC Filing
Giles Mark T 4
Accession 0001437749-19-014277
CIK 0001053691other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 3:00 PM ET
Size
6.7 KB
Accession
0001437749-19-014277
Insider Transaction Report
Form 4
Giles Mark T
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+13,100→ 13,100 totalExercise: $3.15Exp: 2029-06-13→ Common Stock (13,100 underlying)
Holdings
- 294(indirect: By IRA)
Common Stock
- 53,513(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on June 13, 2019.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001663219
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 3:00 PM ET
- Size
- 6.7 KB